Literature DB >> 20138022

Effects of protons on macroscopic and single-channel currents mediated by the human P2X7 receptor.

B Flittiger1, M Klapperstück, G Schmalzing, F Markwardt.   

Abstract

Human P2X7 receptors (hP2X7Rs) belong to the P2X family, which opens an intrinsic cation channel when challenged by extracellular ATP. hP2X7Rs are expressed in cells of the inflammatory and immune system. During inflammation, ATP and protons are secreted into the interstitial fluid. Therefore, we investigated the effect of protons on the activation of hP2X7Rs. hP2X7Rs were expressed in Xenopus laevis oocytes and activated by the agonists ATP or benzoyl-benzoyl-ATP (BzATP) at different pH values. The protons reduced the hP2X7R-dependent cation current amplitude and slowed the current deactivation depending on the type and concentration of the agonist used. These effects can be explained by (i) the protonation of ATP, which reduces the effective concentration of the agonist ATP(4-) at the high- and low-affinity ATP activation site of the hP2XR, and (ii) direct allosteric inhibition of the hP2X7R channel opening that follows ATP(4-) binding to the low-affinity activation site. Due to the hampered activation via the low-affinity activation site, a low pH (as observed in inflamed tissues) leads to a relative increase in the contribution of the high-affinity activation site for hP2X7R channel opening. 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20138022     DOI: 10.1016/j.bbamem.2010.01.023

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  9 in total

Review 1.  Regulation of ATP-gated P2X channels: from redox signaling to interactions with other proteins.

Authors:  Stanko S Stojilkovic; Elías Leiva-Salcedo; Milos B Rokic; Claudio Coddou
Journal:  Antioxid Redox Signal       Date:  2013-09-25       Impact factor: 8.401

Review 2.  Activation and regulation of purinergic P2X receptor channels.

Authors:  Claudio Coddou; Zonghe Yan; Tomas Obsil; J Pablo Huidobro-Toro; Stanko S Stojilkovic
Journal:  Pharmacol Rev       Date:  2011-07-07       Impact factor: 25.468

3.  Acupuncture alleviates acid- and purine-induced pain in rodents.

Authors:  Ying Zhang; Lumei Huang; Sergey A Kozlov; Patrizia Rubini; Yong Tang; Peter Illes
Journal:  Br J Pharmacol       Date:  2019-11-21       Impact factor: 8.739

4.  Homodimeric anoctamin-1, but not homodimeric anoctamin-6, is activated by calcium increases mediated by the P2Y1 and P2X7 receptors.

Authors:  Michaela Stolz; Manuela Klapperstück; Thomas Kendzierski; Silvia Detro-Dassen; Anna Panning; Günther Schmalzing; Fritz Markwardt
Journal:  Pflugers Arch       Date:  2015-01-17       Impact factor: 3.657

5.  Established Protocols for cRNA Expression and Voltage-Clamp Characterization of the P2X7 Receptor in Xenopus laevis Oocytes.

Authors:  Günther Schmalzing; Fritz Markwardt
Journal:  Methods Mol Biol       Date:  2022

6.  Low pH of interstitial fluid around hippocampus of the brain in diabetic OLETF rats.

Authors:  Yoshinori Marunaka; Kanji Yoshimoto; Wataru Aoi; Shigekuni Hosogi; Hiroshi Ikegaya
Journal:  Mol Cell Ther       Date:  2014-03-01

7.  Acidification changes affect the inflammasome in human nucleus pulposus cells.

Authors:  Frank J Brand; Mahtab Forouzandeh; Harmanpreet Kaur; Francesco Travascio; Juan Pablo de Rivero Vaccari
Journal:  J Inflamm (Lond)       Date:  2016-08-24       Impact factor: 4.981

8.  Interaction of Purinergic P2X4 and P2X7 Receptor Subunits.

Authors:  Markus Schneider; Kirsten Prudic; Anja Pippel; Manuela Klapperstück; Ursula Braam; Christa E Müller; Günther Schmalzing; Fritz Markwardt
Journal:  Front Pharmacol       Date:  2017-11-22       Impact factor: 5.810

9.  Dihydropyridines Potentiate ATP-Induced Currents Mediated by the Full-Length Human P2X5 Receptor.

Authors:  Ida C Schiller; Kenneth A Jacobson; Zhiwei Wen; Aparna Malisetty; Günther Schmalzing; Fritz Markwardt
Journal:  Molecules       Date:  2022-03-11       Impact factor: 4.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.